advertisement
11.17 Cooperation with medical therapy e.g. persistency, compliance, adherence (5)
Showing records 1 to 5
Search within classification 11.17 Cooperation with medical therapy e.g. persistency, compliance, adherence19495 Risk factors for noncompliance with follow-up among normal-tension glaucoma suspects
Ngan R; Lam DL; Mudumbai RC; Chen PP
American Journal of Ophthalmology 2007; 144: 310-311
19313 Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol
Dunker S; Schmucker A; Maier H
Advances in Therapy 2007; 24: 376-386
19410 Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a medicare managed care population
Bhosle MJ; Reardon G; Camacho FT; Anderson RT; Balkrishnan R
American Journal Geriatric Pharmacotherapy 2007; 5: 100-111
19548 Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma
Jayawant SS; Bhosle MJ; Anderson RT; Balkrishnan R
Journal of Glaucoma 2007; 16: 513-520
19587 Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: The Glaucoma Adherence and Persistency Study
Quigley HA; Friedman DS; Hahn SR
Ophthalmology 2007; 114: 1599-1606
